International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world's finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY. |  |
|
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Palau Hernandez Margarita | Director | May 19 '25 | Buy | 77.42 | 850 | 65,807 | 2,393 | May 20 01:33 PM | | Yildiz Beril | CAO, SVP & Controller | May 19 '25 | Sale | 77.33 | 2,400 | 185,604 | 3,321 | May 19 05:09 PM | | Landsman Stephen N | EVP, General Counsel | May 19 '25 | Buy | 77.28 | 12,000 | 927,356 | 12,000 | May 19 05:08 PM | | Yildiz Beril | Officer | May 19 '25 | Proposed Sale | 77.33 | 2,400 | 185,604 | | May 19 01:12 PM | | Yildiz Beril | CAO, SVP & Controller | May 05 '25 | Option Exercise | 0.00 | 849 | 0 | 6,028 | May 16 09:01 PM | | Yildiz Beril | CAO, SVP & Controller | May 01 '25 | Option Exercise | 0.00 | 952 | 0 | 5,523 | May 16 09:01 PM | | Finzel Ralf | EVP, Global Operations Officer | May 05 '25 | Option Exercise | 0.00 | 1,326 | 0 | 9,976 | May 16 09:01 PM | | Finzel Ralf | EVP, Global Operations Officer | May 01 '25 | Option Exercise | 0.00 | 1,984 | 0 | 9,663 | May 16 09:01 PM | | DeVeau Michael | EVP, CFO | May 05 '25 | Option Exercise | 0.00 | 884 | 0 | 11,048 | May 16 09:01 PM | | DeVeau Michael | EVP, CFO | May 01 '25 | Option Exercise | 0.00 | 1,389 | 0 | 10,874 | May 16 09:01 PM | | Borg Deborah | EVP, Chief Ppl&Culture Officer | May 05 '25 | Option Exercise | 0.00 | 1,768 | 0 | 28,383 | May 16 09:00 PM | | Borg Deborah | EVP, Chief Ppl&Culture Officer | May 01 '25 | Option Exercise | 0.00 | 2,381 | 0 | 27,817 | May 16 09:00 PM | | Palau Hernandez Margarita | Director | May 01 '25 | Option Exercise | 0.00 | 1,543 | 0 | 1,543 | May 16 08:57 PM | | O'Byrne Kevin | Director | May 01 '25 | Option Exercise | 0.00 | 1,875 | 0 | 3,590 | May 16 08:56 PM | | Khan Mehmood | Director | May 15 '25 | Buy | 75.33 | 4,000 | 301,314 | 4,604 | May 15 05:27 PM | | Fyrwald J Erik | Chief Executive Officer | May 09 '25 | Buy | 73.97 | 24,300 | 1,797,456 | 62,070 | May 09 05:03 PM | | Fyrwald J Erik | Chief Executive Officer | May 08 '25 | Buy | 74.00 | 700 | 51,797 | 37,770 | May 09 05:03 PM | | JAMISON CYNTHIA T | Director | May 01 '25 | Option Exercise | 0.00 | 604 | 0 | 604 | May 05 05:51 PM | | INTRIERI VINCENT J | Director | May 01 '25 | Option Exercise | 0.00 | 604 | 0 | 604 | May 05 05:50 PM | | Costa Mark J | Director | May 01 '25 | Option Exercise | 0.00 | 1,875 | 0 | 4,014 | May 05 05:50 PM | | Khan Mehmood | Director | May 01 '25 | Option Exercise | 0.00 | 604 | 0 | 604 | May 05 05:47 PM | | Fyrwald J Erik | Chief Executive Officer | May 01 '25 | Option Exercise | 0.00 | 15,875 | 0 | 45,175 | May 05 05:46 PM | | Strzelecki Angela | President, Pharma Solutions | Apr 04 '25 | Option Exercise | 0.00 | 1,761 | 0 | 10,362 | Apr 07 04:17 PM | | DeVeau Michael | CFO | Apr 04 '25 | Option Exercise | 0.00 | 1,993 | 0 | 10,204 | Apr 07 04:16 PM | | Borg Deborah | EVP, Chief Ppl&Culture Officer | Apr 04 '25 | Option Exercise | 0.00 | 4,602 | 0 | 27,981 | Apr 07 04:16 PM | | O'Byrne Kevin | Director | Mar 05 '25 | Buy | 80.44 | 6,500 | 522,833 | 6,500 | Mar 06 05:13 PM | | Fyrwald J Erik | CEO | Mar 04 '25 | Buy | 80.24 | 25,000 | 2,005,878 | 29,300 | Mar 05 04:08 PM | | Finzel Ralf | EVP, Global Operations Officer | Dec 02 '24 | Option Exercise | 0.00 | 5,387 | 0 | 9,622 | Dec 03 04:05 PM | | Arora Yuvraj | President, Nourish | Nov 11 '24 | Sale | 91.75 | 5,000 | 458,775 | 3,238 | Nov 12 04:20 PM | | Arora Yuvraj | Officer | Nov 11 '24 | Proposed Sale | 91.75 | 5,000 | 458,775 | | Nov 12 09:07 AM | | RICHTER GLENN R | CFO | Oct 01 '24 | Option Exercise | 0.00 | 11,812 | 0 | 32,171 | Oct 03 04:20 PM | | Borg Deborah | EVP, Chief HR and D&I Officer | Sep 03 '24 | Option Exercise | 0.00 | 13,807 | 0 | 30,282 | Sep 05 04:05 PM | | Herriott Simon | Pres. Health & Bioscience | Jul 03 '24 | Option Exercise | 0.00 | 627 | 0 | 10,759 | Jul 05 04:10 PM | | Strzelecki Angela | President, Pharma Solutions | Jun 13 '24 | Option Exercise | 77.16 | 2,588 | 199,690 | 11,127 | Jun 14 04:56 PM | | Strzelecki Angela | President, Pharma Solutions | Jun 13 '24 | Sale | 95.66 | 2,588 | 247,560 | 8,539 | Jun 14 04:56 PM |
|
